Eylea biosimilar – Talk Bio

Actionable Insights Powered by AI

Federal Circuit ruling allows Amgen’s Eylea biosimilar to stay on the market

Market, Amgen ‘s, Pavblu, Amgen, Eylea biosimilar, Regeneron, Federal Circuit, court, Eylea